Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications

Bone marrow stromal cells are progenitors of skeletal tissue components such as bone, cartilage, the hematopoiesis‐supporting stroma, and adipocytes. In addition, they may be experimentally induced to undergo unorthodox differentiation, possibly forming neural and myogenic cells. As such, they represent an important paradigm of post‐natal nonhematopoietic stem cells, and an easy source for potential therapeutic use. Along with an overview of the basics of their biology, we discuss here their potential nature as components of the vascular wall, and the prospects for their use in local and systemic transplantation and gene therapy.

[1]  I. Black,et al.  Adult rat and human bone marrow stromal cells differentiate into neurons , 2000, Journal of neuroscience research.

[2]  Darwin J. Prockop,et al.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.

[3]  D. Rowe,et al.  Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. , 1997, Transplantation.

[4]  G. Gahrton,et al.  Retroviral‐mediated gene transfer into human bone marrow stromal cells: Studies of efficiency and in vivo survival in SCID mice , 1995, European journal of haematology.

[5]  B. Péault,et al.  Transplantation of gene-modified human bone marrow stromal cells into mouse-human bone chimeras. , 2000, Journal of hematotherapy & stem cell research.

[6]  J. Palmblad,et al.  Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. , 2000, The American journal of pathology.

[7]  上松 一永.  Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans , 1992 .

[8]  J. Singer,et al.  CGA-7 and HHF, two monoclonal antibodies that recognize muscle actin and react with adherent cells in human long-term bone marrow cultures. , 1985, Blood.

[9]  A. Friedenstein,et al.  Marrow microenvironment transfer by heterotopic transplantation of freshly isolated and cultured cells in porous sponges. , 1982, Experimental hematology.

[10]  Friedenstein Aj,et al.  Marrow microenvironment transfer by heterotopic transplantation of freshly isolated and cultured cells in porous sponges. , 1982 .

[11]  P. Bianco,et al.  Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. , 1998, The Journal of clinical investigation.

[12]  B. Frenkel,et al.  Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  N. Kulagina,et al.  Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. , 1974, Experimental Hematology.

[14]  S. Mckercher,et al.  Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. , 2000, Science.

[15]  D. Benayahu,et al.  Single‐Colony Derived Strains of Human Marrow Stromal Fibroblasts Form Bone After Transplantation In Vivo , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  A. Friedenstein,et al.  Osteogenesis in transplants of bone marrow cells. , 1966, Journal of embryology and experimental morphology.

[17]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[18]  S. Bruder,et al.  Discrete stages within the osteogenic lineage are revealed by alterations in the cell surface architecture of embryonic bone cells. , 1989, Connective tissue research.

[19]  T. VandenDriessche,et al.  Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice. , 2000, Human gene therapy.

[20]  J. Scott.  Oxygen and the connective tissues. , 1992, Trends in biochemical sciences.

[21]  W. Hunter,et al.  Rearrangement of the metaphyseal vasculature of the rat growth plate in rickets and rachitic reversal: A model of vascular arrest and angiogenesis renewed , 1991, The Anatomical record.

[22]  V. Goldberg,et al.  The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. , 1991, Clinical orthopaedics and related research.

[23]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[24]  J. Rémy-Martin,et al.  Retroviral-mediated marker gene transfer in hematopoiesis-supportive marrow stromal cells. , 1998, Journal of Hematotherapy.

[25]  D. Ma,et al.  Chromosomal analysis of bone marrow stromal fibroblasts in allogeneic HLA compatible sibling bone marrow transplantations. , 1987, Leukemia research.

[26]  S. Jhanwar,et al.  Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation. , 1987, Blood.

[27]  R. Cancedda,et al.  Hypertrophic chondrocytes undergo further differentiation to osteoblast‐like cells and participate in the initial bone formation in developing chick embryo , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  P. Rooney,et al.  Bone-marrow-derived chondrogenesis in vitro. , 1992, Journal of cell science.

[29]  S. Gronthos,et al.  Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Chalmers.  The Biochemistry and Physiology of Bone , 1973 .

[31]  E. Bonucci,et al.  Alkaline phosphatase positive precursors of adipocytes in the human bone marrow , 1988, British journal of haematology.

[32]  L. Weiss.  Haemopoiesis in mammalian bone marrow. , 1981, Ciba Foundation symposium.

[33]  R. Gutiérrez,et al.  Inducible perivascular cells contribute to the neochondrogenesis in grafted perichondrium , 1991, The Anatomical record.

[34]  R R Markwald,et al.  Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. , 1997, Circulation research.

[35]  L. Humeau,et al.  Early ontogeny of the human marrow from long bones: an immunohistochemical study of hematopoiesis and its microenvironment. , 1996, Blood.

[36]  V. Lanzov.  Gene targeting for gene therapy: prospects. , 1999, Molecular genetics and metabolism.

[37]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[38]  J. Triffitt,et al.  Adipocytic cells cultured from marrow have osteogenic potential. , 1991, Journal of cell science.

[39]  S. Gronthos,et al.  MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies , 1998, Leukemia.

[40]  R. Gutiérrez,et al.  Pericytes as a supplementary source of osteoblasts in periosteal osteogenesis. , 1992, Clinical orthopaedics and related research.

[41]  A. Vescovi,et al.  Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. , 1999, Science.

[42]  R. Mulligan,et al.  Dystrophin expression in the mdx mouse restored by stem cell transplantation , 1999, Nature.

[43]  S. Gronthos,et al.  Isolation, characterization and functional activity of human marrow stromal progenitors in hemopoiesis. , 1994 .

[44]  G. Gabbiani,et al.  α-Smooth muscle actin is expressed in a subset of bone marrow stromal cells in normal and pathological conditions , 1989 .

[45]  G. Gabbiani,et al.  Alpha-smooth muscle actin is expressed in a subset of bone marrow stromal cells in normal and pathological conditions. , 1989, Virchows Archiv. B, Cell pathology including molecular pathology.

[46]  K. Jen,et al.  Suppression of Gene Expression by Targeted Disruption of Messenger RNA: Available Options and Current Strategies , 2000, Stem cells.

[47]  P. Robbins,et al.  Insulinlike Growth Factor-I Gene Therapy Applications for Cartilage Repair , 2000, Clinical orthopaedics and related research.

[48]  A. Friedenstein,et al.  THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS , 1970, Cell and tissue kinetics.

[49]  P. Bianco,et al.  Marrow Stromal Cell Culture: The bone marrow stroma in vivo : ontogeny, structure, cellular composition and changes in disease , 1998 .

[50]  D. Gazit,et al.  Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell‐mediated gene therapy , 1999, The journal of gene medicine.

[51]  S. Gronthos,et al.  The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. , 1994, Blood.

[52]  E. Keshet,et al.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.

[53]  N. Morel,et al.  Pericyte physiology , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  C. Devlin,et al.  Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. , 1992, Journal of cell science.

[55]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[56]  K. Satomura,et al.  Osteogenic imprinting upstream of marrow stromal cell differentiation , 2000, Journal of cellular biochemistry.

[57]  K. Agematsu,et al.  Recipient origin of bone marrow‐derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans , 1991, British journal of haematology.

[58]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[59]  S. Gronthos,et al.  The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. , 1995, Blood.

[60]  A. Canfield,et al.  Vascular Pericytes Express Osteogenic Potential In Vitro and In Vivo , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[61]  A. Friedenstein,et al.  Factors required for bone marrow stromal fibroblast colony formation in vitro , 1997, British journal of haematology.

[62]  D. Rowe,et al.  Receptor tyrosine kinase expression in human bone marrow stromal cells , 1998, Journal of cellular physiology.

[63]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[64]  R. Gutiérrez,et al.  Microvascular pericytes: a review of their morphological and functional characteristics. , 1991, Histology and histopathology.

[65]  C. Betsholtz,et al.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.

[66]  J. Allay,et al.  LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. , 1997, Human gene therapy.

[67]  B. Frenkel,et al.  Cells Capable of Bone Production Engraft from Whole Bone Marrow Transplants in Nonablated Mice , 1999, The Journal of experimental medicine.

[68]  Napoleone Ferrara,et al.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.

[69]  S. Kadiyala,et al.  Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. , 1997, Cell transplantation.

[70]  M. Iadarola,et al.  Genomic integration and gene expression by a modified adenoviral vector , 2000, Nature Biotechnology.

[71]  P. Simmons,et al.  Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. , 1991, Blood.

[72]  N. Wright,et al.  Induction of Bone Formation Using a Recombinant Adenoviral Vector Carrying the Human BMP-2 Gene in a Rabbit Spinal Fusion Model , 1998, Calcified Tissue International.

[73]  D. Sims,et al.  The pericyte--a review. , 1986, Tissue & cell.

[74]  N. Munshi,et al.  Bone marrow stromal cells as a vehicle for gene transfer , 1999, Gene Therapy.

[75]  C. R. Howlett,et al.  Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. , 1980, Clinical orthopaedics and related research.

[76]  P. Bianco,et al.  Marrow stromal stem cells. , 2000, The Journal of clinical investigation.

[77]  A I Caplan,et al.  In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. , 1998, Experimental cell research.

[78]  G. Cossu,et al.  Uno, nessuno e centomila: searching for the identity of mesodermal progenitors. , 1999, Experimental cell research.

[79]  D. Lorich,et al.  The pericyte as a possible osteoblast progenitor cell. , 1992, Clinical orthopaedics and related research.

[80]  E. Andreeva,et al.  Continuous subendothelial network formed by pericyte-like cells in human vascular bed. , 1998, Tissue & cell.

[81]  Richard A. Flavell,et al.  Death by numbers , 2000, Nature Biotechnology.

[82]  R. Cancedda,et al.  Vis‐à‐Vis Cells and the Priming of Bone Formation , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[83]  R. Cancedda,et al.  Cell proliferation, extracellular matrix mineralization, and ovotransferrin transient expression during in vitro differentiation of chick hypertrophic chondrocytes into osteoblast-like cells , 1993, The Journal of cell biology.

[84]  P. Dawson,et al.  Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts. , 2000, Nucleic acids research.

[85]  M Oyama,et al.  Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging , 1999, Gene Therapy.

[86]  P. Bianco,et al.  An animal model of fibrous dysplasia. , 1999, Molecular medicine today.

[87]  K. Hirschi,et al.  Control of angiogenesis by the pericyte: molecular mechanisms and significance. , 1997, EXS.

[88]  A Boyde,et al.  Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. , 2000, Journal of biomedical materials research.

[89]  Xin Wang,et al.  Purified hematopoietic stem cells can differentiate into hepatocytes in vivo , 2000, Nature Medicine.

[90]  A. Canfield,et al.  Gene expression during vascular pericyte differentiation. , 1999, Critical reviews in eukaryotic gene expression.

[91]  M. D. Baker,et al.  Mechanisms involved in targeted gene replacement in mammalian cells. , 2000, Genetics.

[92]  W. Anderson,et al.  Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX. , 1997, Human gene therapy.

[93]  R. Nicosia,et al.  Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[94]  P. Bianco,et al.  Multipotential cells in the bone marrow stroma: regulation in the context of organ physiology. , 1999, Critical reviews in eukaryotic gene expression.

[95]  J. Aubin,et al.  Cell sorting enriches osteogenic populations in rat bone marrow stromal cell cultures. , 1997, Bone.

[96]  V. Koteliansky,et al.  Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. , 1993, Blood.

[97]  V. Goldberg,et al.  The Effect of Implants Loaded with Autologous Mesenchymal Stem Cells on the Healing of Canine Segmental Bone Defects* , 1998, The Journal of bone and joint surgery. American volume.

[98]  P. Bianco,et al.  CHAPTER 14 – Cellular Mechanisms of Age-Related Bone Loss , 1999 .

[99]  Jun Yamashita,et al.  Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors , 2000, Nature.

[100]  J. Triffitt,et al.  Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies. , 1997, Bone.

[101]  A. Caplan,et al.  Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. , 1992, Bone.

[102]  K. Satomura,et al.  Repair of craniotomy defects using bone marrow stromal cells. , 1998, Transplantation.

[103]  Alan W. Flake,et al.  Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep , 2000, Nature Medicine.

[104]  G. Finerman,et al.  Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[105]  A. Ascenzi.  CHAPTER 10 – Physiological Relationship and Pathological Interferences between Bone Tissue and Marrow , 1976 .

[106]  S. Gronthos,et al.  The biology and application of human bone marrow stromal cell precursors. , 1996, Journal of hematotherapy.

[107]  J. Ward,et al.  MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover , 1999, Cell.

[108]  D. Prockop,et al.  Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. , 1999, Human gene therapy.

[109]  D J Prockop,et al.  Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. , 1999, Proceedings of the National Academy of Sciences of the United States of America.